BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28163764)

  • 1. Optical Coherence Tomography in Patients with Relapsing-Remitting Multiple Sclerosis without Optic Neuritis: A 20-Month Longitudinal Study.
    Huseyinoglu N; Ozben S; Ekinci M; Buyukuysal C; Yıldırım M; Safak H; Huseyin H
    Neuroophthalmology; 2013; 37(3):104-110. PubMed ID: 28163764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography with voxel-based morphometry: a new tool to unveil focal retinal neurodegeneration in multiple sclerosis.
    Huang SC; Pisa M; Guerrieri S; Dalla Costa G; Comi G; Leocani L
    Brain Commun; 2024; 6(1):fcad249. PubMed ID: 38328398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of macular and nerve fiber layer thickness in multiple sclerosis patients according to severity level and optic neuritis episodes.
    Soler García A; Padilla Parrado F; Figueroa-Ortiz LC; González Gómez A; García-Ben A; García-Ben E; García-Campos JM
    Neurologia; 2016; 31(6):379-88. PubMed ID: 25529178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
    Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
    Martinez-Lapiscina EH; Arnow S; Wilson JA; Saidha S; Preiningerova JL; Oberwahrenbrock T; Brandt AU; Pablo LE; Guerrieri S; Gonzalez I; Outteryck O; Mueller AK; Albrecht P; Chan W; Lukas S; Balk LJ; Fraser C; Frederiksen JL; Resto J; Frohman T; Cordano C; Zubizarreta I; Andorra M; Sanchez-Dalmau B; Saiz A; Bermel R; Klistorner A; Petzold A; Schippling S; Costello F; Aktas O; Vermersch P; Oreja-Guevara C; Comi G; Leocani L; Garcia-Martin E; Paul F; Havrdova E; Frohman E; Balcer LJ; Green AJ; Calabresi PA; Villoslada P;
    Lancet Neurol; 2016 May; 15(6):574-84. PubMed ID: 27011339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography.
    Saidha S; Syc SB; Ibrahim MA; Eckstein C; Warner CV; Farrell SK; Oakley JD; Durbin MK; Meyer SA; Balcer LJ; Frohman EM; Rosenzweig JM; Newsome SD; Ratchford JN; Nguyen QD; Calabresi PA
    Brain; 2011 Feb; 134(Pt 2):518-33. PubMed ID: 21252110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular spectral domain optical coherence tomography findings in Tanzanian endemic optic neuropathy.
    Kisimbi J; Shalchi Z; Mahroo OA; Mhina C; Sanyiwa AJ; Mabey D; Mohamed M; Plant GT
    Brain; 2013 Nov; 136(Pt 11):3418-26. PubMed ID: 24018312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.
    Henderson AP; Altmann DR; Trip AS; Kallis C; Jones SJ; Schlottmann PG; Garway-Heath DF; Plant GT; Miller DH
    Brain; 2010 Sep; 133(9):2592-602. PubMed ID: 20566483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography.
    Albrecht P; Ringelstein M; Müller AK; Keser N; Dietlein T; Lappas A; Foerster A; Hartung HP; Aktas O; Methner A
    Mult Scler; 2012 Oct; 18(10):1422-9. PubMed ID: 22389411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography.
    Monteiro ML; Fernandes DB; Apóstolos-Pereira SL; Callegaro D
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3959-66. PubMed ID: 22589446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of macular ganglion cell loss in preperimetric glaucoma patients with localized retinal nerve fibre defects by spectral-domain optical coherence tomography.
    Na JH; Lee K; Lee JR; Baek S; Yoo SJ; Kook MS
    Clin Exp Ophthalmol; 2013 Dec; 41(9):870-80. PubMed ID: 23777476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced retinal nerve fiber layer and macular thickness in patients with multiple sclerosis with no history of optic neuritis identified by the use of spectral domain high-definition optical coherence tomography.
    Fjeldstad C; Bemben M; Pardo G
    J Clin Neurosci; 2011 Nov; 18(11):1469-72. PubMed ID: 21917458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Structural and Functional Assessment of the Visual System in Mildly Disabled Relapsing-Remitting Multiple Sclerosis Patients.
    Huseyinoglu N; Ekinci M; Ozben S; Buyukuysal C
    Neuroophthalmology; 2014; 38(1):1-7. PubMed ID: 27928266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography.
    Costello F; Hodge W; Pan YI; Eggenberger E; Coupland S; Kardon RH
    Mult Scler; 2008 Aug; 14(7):893-905. PubMed ID: 18573837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.
    Graham EC; You Y; Yiannikas C; Garrick R; Parratt J; Barnett MH; Klistorner A
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2311-7. PubMed ID: 27127930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis.
    Burkholder BM; Osborne B; Loguidice MJ; Bisker E; Frohman TC; Conger A; Ratchford JN; Warner C; Markowitz CE; Jacobs DA; Galetta SL; Cutter GR; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2009 Nov; 66(11):1366-72. PubMed ID: 19901168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.
    Pueyo V; Martin J; Fernandez J; Almarcegui C; Ara J; Egea C; Pablo L; Honrubia F
    Mult Scler; 2008 Jun; 14(5):609-14. PubMed ID: 18424482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis.
    Soufi G; AitBenhaddou E; Hajji Z; Tazrout S; Benomar A; Soufi M; Boulanouar A; Abouqal R; Yahyaoui M; Berraho A
    J Fr Ophtalmol; 2015 Jun; 38(6):497-503. PubMed ID: 25896580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of spectral domain optical coherence tomography measurements in optic neuritis: differences in neuromyelitis optica, multiple sclerosis, isolated optic neuritis and normal healthy controls.
    Park KA; Kim J; Oh SY
    Acta Ophthalmol; 2014 Feb; 92(1):e57-65. PubMed ID: 23889747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced retinal nerve fiber layer thickness and macular volume in pediatric multiple sclerosis.
    Yilmaz Ü; Gücüyener K; Erin DM; Yazar Z; Gürkaş E; Serdaroğlu A; Tepe N; Demir E
    J Child Neurol; 2012 Dec; 27(12):1517-23. PubMed ID: 22752482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.